TrademarkDir
OMNIVIUM PHARMACEUTICALS
LIVE

Serial Number

90839896

Owner

Omnivium Pharmaceuticals LLC

Attorney

Michael C. Cannata

First Use Date

Oct 15, 2023

Filing Date

Jul 21, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OMNIVIUM PHARMACEUTICALS Trademark

Serial Number: 90839896 • Registration: 7495809

OMNIVIUM PHARMACEUTICALS is a trademark filed by Omnivium Pharmaceuticals LLC on July 21, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Omnivium Pharmaceuticals LLC (5 trademarks)

2131 Felver Court, Suite A
Rahway, NJ 07065

Entity Type: 16

Trademark Details

Filing Date

July 21, 2021

Registration Date

September 3, 2024

First Use Anywhere

October 15, 2023

First Use in Commerce

October 15, 2023

Published for Opposition

September 27, 2022

Goods & Services

pharmaceutical products and preparations for curing, halting and preventing cardiovascular, bacterial, viral, psychiatric, eye, central nervous system, gastrointestinal, and cancer related diseases, easing symptoms, or helping in the diagnosis of illnesses; house mark for a full line of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 31, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 31, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2024 CRFA
ASSIGNED TO LIE
Jul 30, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 28, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 5, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 5, 2023 AITU
USE AMENDMENT FILED
Nov 22, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 22, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 24, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 22, 2023 EX1G
SOU EXTENSION 1 FILED
May 22, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 22, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 24, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 14, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 23, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2021 NWOS
NEW APPLICATION ENTERED
Jul 24, 2021 NWAP

Related Trademarks

More from this Owner

OMNIVIUM

OMNIVIUM

OMNIVIUM

OMNIVIUM

OMNIVIUM PHARMA

OMNIVIUM PHARMA

OMNIVIUM PHARMA

OMNIVIUM PHARMA

OMNIVIUM PHARMACEUTICALS

OMNIVIUM PHARMACEUTICALS

OMNIVIUM PHARMACEUTICALS

OMNIVIUM PHARMACEUTICALS